Metraipolis › archive › dc_d4fb2e04a98a
One-year results of the intravitreal administration of faricimab in patients with naïve type 3 macular neovascularization — Europe PMC PMID:41664225
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41664225
- DOI
- 10.1186/s40942-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T00:50:47.585Z
- SHA-256 of the archived text
1e8684fbf180a4a9e06cf62903a8aac486a320e6001f400972e660546bf85ba9- Stable URL of this page
https://metraipolis.com/documento/dc_d4fb2e04a98a
How to cite
One-year results of the intravitreal administration of faricimab in patients with naïve type 3 macular neovascularization — Europe PMC PMID:41664225 — Europe PMC (en), https://europepmc.org/article/MED/41664225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d4fb2e04a98a (Metraipolis archive dc_d4fb2e04a98a, sha256 1e8684fbf180a4a9e06cf62903a8aac486a320e6001f400972e660546bf85ba9)
BibTeX
@misc{dcd4fb2e04a98a,
title = {One-year results of the intravitreal administration of faricimab in patients with naïve type 3 macular neovascularization — Europe PMC PMID:41664225},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41664225},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d4fb2e04a98a; sha256 1e8684fbf180a4a9e06cf62903a8aac486a320e6001f400972e660546bf85ba9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41664225. Agents can read the archived copy with the MCP tool read_document.